Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Neoadjuvant Therapy for Esophageal Cancer:A Multicenter Phase II Clinical Trail

NCT06990178 is registered in ClinicalTrials.gov with Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center as lead sponsor.

NCT NCT06990178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06990178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Neoadjuvant Therapy for Esophageal Cancer:A Multicenter Phase II Clinical Trail
Lead sponsor
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 1, 2028
Completion date
March 31, 2028
Enrollment
43 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal carcinoma, neoadjuvant therapy